Clinical Trials in Tennessee

Showing 17161-17180 of 17,345 trials

A Trial Of Gemcitabine Plus Paclitaxel And Gemcitabine Plus Docetaxel In Metastatic Breast Cancer

NCT00191672

The combination of docetaxel and gemcitabine has shown significant activity in patients with metastatic breast cancer. Several studies have activity in patients of multiple lines of therapy, including patients that have been treated with prior taxane therapy. Overall responses have ranged from 30% to 79%. The major side effects of the combination chemotherapy have been neutropenia, anemia, asthenia, neuropathy, nausea, mucositis, and neutropenic fever

Breast Neoplasms

Eli Lilly and Company120 participantsStarted Dec 2003

Nashville, Tennessee, United States • Katy, Texas, United States

UNKNOWNPhase 1/229 miles

Safety and Immunogenicity Study of LC16m8, a Modified Smallpox Vaccine, in Healthy, Previously Unvaccinated Volunteers

NCT00103584

This is a Phase I/II study evaluating the safety and immunogenicity of LC16m8, a modified vaccinia vaccine. After consent and thorough screening (including safety labs, EKG, and medical history), healthy, previously unvaccinated volunteers between the ages of 18-34 will receive a single vaccination of either LC16m8 or the current US-licensed smallpox vaccine, Dryvax. Volunteers will be blindly randomized to a treatment group in a 4:1 ratio (4 LC16m8 to 1 Dryvax recipient). Follow-up clinical evaluations, laboratory testing, EKGs and cardiac assessments will be done at regularly scheduled follow-up visits for 1 year after vaccination.

Smallpox

VaxGen150 participantsStarted Oct 2004

Stanford, California, United States • Lexington, Kentucky, United States • St Louis, Missouri, United States +1 more locations

A Trial Of Gemcitabine Plus Paclitaxel And Gemcitabine Plus Docetaxel In Metastatic Breast Cancer

Safety and Immunogenicity Study of LC16m8, a Modified Smallpox Vaccine, in Healthy, Previously Unvaccinated Volunteers

Find Trials by Condition in Tennessee

To Evaluate the Long-Term Safety of Pregabalin in Refractory Partial Epilepsy.

Study Evaluating MST-997 in Advanced Malignant Solid Tumors

A Phase 2, Randomized, Open-Label Study Of Single Agent CI-1033 In Patients With Advanced Non-Small Cell Lung Cancer

Evaluation of Intravenous Levosimendan Efficacy in the Short Term Treatment of Decompensated Chronic Heart Failure.

3-D Laser Imaging to Analyze Neck Movement

Study Evaluating the Safety & Efficacy of DVS-223 SR for Relief of Vasomotor Symptoms Associated With Menopause

Autologous T Cell Immunotherapy for Chronic Lymphocytic Leukemia (CLL) Patients

Evaluation of Argatroban Injection in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin

Study for Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)

APC-231 Once a Day (QD) for 7 Days vs. Penicillin Taken Four Times a Day (QID) in Pediatric Patients With Strep Throat

T Cell Immunotherapy for Multiple Myeloma Patients Undergoing a Bone Marrow Transplant

Pemetrexed Plus Gemcitabine for Patients With Locally Advanced or Metastatic NSCLC Who Have Not Had Previous Chemotherapy.

A Study of Pemetrexed in Small Cell Lung Cancer, Which Has Returned

SP01A: The Study of an Oral Entry Inhibitor in Treatment-Experienced HIV Patients

Safety and Immunogenicity of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small Cell Lung Cancer

Chemotherapy for Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Effectiveness of Duloxetine in the Treatment of Stress Urinary Incontinence(Uncontrolled Leakage of Urine)

Bipolar Depression Study: Bipolar Depression Assessment Study on Treatment Response